LONDON, UK, September 1, 2025 — Willis, a WTW business (NASDAQ: WTW), has launched the first specialty bloodstock insurance product with Equine MediRecord to make the purchasing of bloodstock insurance more accessible and efficient for horse owners and trainers in the UK.
Willis have signed a deal with Equine MediRecord, a leading vertical SaaS platform in equine digital health software and part of Canada-based Inova Group’s Business Infusions - the largest equine veterinary software group in the world. Equine MediRecord simplifies compliance in adherence to animal welfare and anti-doping regulations as the UK’s only regulator-approved digital medicines register. The subscription-based platform is the first software system to be approved by any equine regulatory body to meet universally stringent reporting requirements. Equine MediRecord is utilised by some of the top horse organisations in the world and by equine regulators in Ireland, United Kingdom, France, United States and Saudi Arabia.
The partnership will also see A-rated global specialty insurer Markel (NYSE: MKL) – the insurance arm of Markel Group Inc, a Fortune 500 company, utilise Willis’ own low-code technology platform to distribute a bloodstock mortality and theft product embedded within the Equine MediRecord platform. The embedded product supported by Kayna’s data-orchestration capabilities, will serve relevant data-led insurance solutions starting with Equine MediRecord’s UK client base which ranges from large stud farms to individual horse owners engaged in the multi-billion euro equine industry.




